Valuation (74%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 22.83 | 17.66 |
PEG Ratio (TTM) | 2.31 | 6.63 |
P/S Ratio (TTM) | 8.67 | 3.06 |
P/B Ratio (TTM) | 2.68 | -5.75 |
P/FCF Ratio (TTM) | 14.83 | 24.49 |
Price to 5YR AVG Earnings Ratio | 10.71 | 32.31 |
Price to 5YR AVG FCF Ratio | 10.20 | 18.94 |
Profitability (60%) |
Company | Industry |
---|---|---|
ROA (TTM) | 4.18% | 6.10% |
ROE (TTM) | 11.86% | -790.55% |
Net Profit Margin (TTM) | 37.99% | 18.35% |
ROIC 5YR AVG | 10.25% | 9.08% |
Growth (40%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 15.22% | -8.19% | 0.60% |
Revenue | 1.76% | 3.37% | 4.03% |
Net Income | 15.01% | -2.25% | 4.04% |
Cash Flow | 4.01% | 10.22% | 7.28% |
Health (33%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.11 | 1.02 |
Quick Ratio (TTM) | 2.15 | 0.88 |
D/E Ratio (TTM) | 1.53 | -3.23 |
Interest Coverage (TTM) | -146.75 | 3.09 |
Piotroski F-Score | 5 | 6 |
Altman Z-Score | 1.17 | 1.59 |
LTL to 5YR AVG FCF | 6.39 | 5.27 |
Shares Outstanding Growth 5YR AVG | 9.95% | 7.84% |